Kynurenines and other novel therapeutic strategies in the treatment of dementia
Dementia is a common neuropsychological disorder with an increasing incidence. The most prevalent type of dementia is Alzheimer’s disease. The underlying pathophysiological features of the cognitive decline are neurodegenerative processes, a cerebrovascular dysfunction and immunological alterations....
Main Authors: | Zsófia Majláth, János Tajti, László Vécsei |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-11-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285613494989 |
Similar Items
-
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
by: Masaru Tanaka, et al.
Published: (2020-01-01) -
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
by: Cecilia Rajda, et al.
Published: (2015-08-01) -
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
by: Tamás Biernacki, et al.
Published: (2020-06-01) -
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
by: Zsuzsanna Bohár, et al.
Published: (2015-04-01) -
Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
by: Fanni A. Boros, et al.
Published: (2019-11-01)